The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late Effects
Open accessAbstract
Purpose: To review the evidence on the incidence of long-term cardiac or pulmonary toxicity secondary to chemotherapy, radiotherapy, or trastuzumab in symptomatic and asymptomatic cancer survivors. Methods: An American Society of Clinical Oncology Panel reviewed pertinent information from the literature through February 2006. Results: Few studies directly addressing the benefits of screening for long-term cardiac or pulmonary toxicity in asymptomatic cancer survivors who received chemotherapy, radiotherapy, or trastuzumab were identified. The reviewed literature included primarily retrospective and cross-sectional studies describing the incidence of cardiac and pulmonary late effects. Anatomic and/or functional abnormalities have been associated with use of all currently available anthracyclines and their derivatives. Trastuzumab-related cardiac dysfunction rarely causes death, and in most cases is reversible with improvement in cardiac function on drug discontinuation and/or treatment with cardiac medications. The estimated aggregate incidence of radiation-induced cardiac disease is 10% to 30% by 5 to 10 years post-treatment, although the incidence may be lower with modern techniques. Radiation pneumonitis is reported in 5% to 15% of lung cancer patients receiving definitive external-beam radiation therapy. A minority of patients may develop progressive pulmonary fibrosis; late complications include cor pulmonale and respiratory failure. Bleomycin-induced pneumonitis is an acute rather than late effect of treatment. Late pulmonary complications in bone marrow or stem cell transplantation patients who develop interstitial pneumonitis include idiopathic pneumonia syndrome and bronchiolitis obliterans. Conclusion: An increased incidence of cardiac and/or pulmonary dysfunction is observed in cancer survivors. Research is needed to identify high-risk patients, and to determine the optimal screening strategies and subsequent treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Romond, E. H., Perez, E. A., Bryant, J., Suman, V. J., Geyer, C. E., Davidson, N. E., Tan-Chiu, E., Martino, S., Paik, S., Kaufman, P. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052122 · Cited by 5,356
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
Chronic Health Conditions in Adult Survivors of Childhood Cancer
Oeffinger, K. C., Mertens, A. C., Sklar, C. A., Kawashima, T., Hudson, M. M., Meadows, A. T., Friedman, D. L., Marina, N., Hobbie, W., Kadan-Lottick, N. S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmsa060185 · Cited by 3,597
Self-citationSwain, S. M., Whaley, F. S., & Ewer, M. S. (2003) · Cancer · doi:10.1002/cncr.11407 · Cited by 2,313
Marty, M., Cognetti, F., Maraninchi, D., Snyder, R., Mauriac, L., Tubiana-Hulin, M., Chan, S., Grimes, D., Antón, A., Lluch, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.173 · Cited by 1,597
Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience
Seidman, A. D., Hudis, C. A., Pierri, M. K., Shak, S., Paton, V. E., Ashby, M. A., Murphy, M., Stewart, S. J., & Keefe, D. L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1215 · Cited by 1,563
Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood
Lipshultz, S. E., Colan, S. D., Gelber, R. D., Perez-Atayde, A. R., Sallan, S. E., & Sanders, S. P. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241205 · Cited by 1,404
Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer
Joensuu, H., Kellokumpu-Lehtinen, P.-L., Bono, P., Alanko, T., Kataja, V., Asola, R., Utriainen, T., Kokko, R., Hemminki, A., Tarkkanen, M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053028 · Cited by 1,403
Buzdar, A. U., Ibrahim, N. K., Francis, D., Booser, D. J., Thomas, E. S., Theriault, R. L., Pusztai, L., Green, M. C., Arun, B. K., Giordano, S. H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.032 · Cited by 1,171
Cardiac Toxicity 4 to 20 Years After Completing Anthracycline Therapy
Steinherz, L. J. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470120074036 · Cited by 989
Cuzick, J., Stewart, H., Rutqvist, L., Houghton, J., Edwards, R., Redmond, C., Peto, R., Baum, M., Fisher, B., & Host, H. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.447 · Cited by 889
Tan-Chiu, E., Yothers, G., Romond, E., Geyer, C. E., Ewer, M., Keefe, D., Shannon, R. P., Swain, S. M., Brown, A., Fehrenbacher, L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.4091 · Cited by 808
Lipshultz, S. E., Lipsitz, S. R., Mone, S. M., Goorin, A. M., Sallan, S. E., Sanders, S. P., Orav, E. J., Gelber, R. D., & Colan, S. D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506293322602 · Cited by 803
Mertens, A. C., Yasui, Y., Neglia, J. P., Potter, J. D., Nesbit, M. E., Ruccione, K., Smithson, W. A., & Robison, L. L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.13.3163 · Cited by 798
Factors Affecting Late Mortality From Heart Disease After Treatment of Hodgkin's Disease
Hancock, S. L. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510160067031 · Cited by 773
Anthracycline-Induced Cardiotoxicity
Shan, K., Lincoff, A. M., & Young, J. B. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00008 · Cited by 749
Lipshultz, S. E., Lipsitz, S. R., Sallan, S. E., Dalton, V. M., Mone, S. M., Gelber, R. D., & Colan, S. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.121 · Cited by 727
Ewer, M. S., Vooletich, M. T., Durand, J.-B., Woods, M. L., Davis, J. R., Valero, V., & Lenihan, D. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.13.300 · Cited by 726
Landier, W., Bhatia, S., Eshelman, D. A., Forte, K. J., Sweeney, T., Hester, A. L., Darling, J., Armstrong, F. D., Blatt, J., Constine, L. S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.032 · Cited by 706
Executive Summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline
Heart Failure Society Of America (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.12.001 · Cited by 683
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.
Swain, S. M., Whaley, F. S., Gerber, M. C., Weisberg, S., York, M., Spicer, D., Jones, S. E., Wadler, S., Desai, A., Vogel, C., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.4.1318 · Cited by 664
Type II Chemotherapy-Related Cardiac Dysfunction: Time to Recognize a New Entity
Ewer, M. S., & Lippman, S. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.827 · Cited by 646
Hull, M. C. (2003) · JAMA · doi:10.1001/jama.290.21.2831 · Cited by 644
Lipshultz, S. E., Rifai, N., Dalton, V. M., Levy, D. E., Silverman, L. B., Lipsitz, S. R., Colan, S. D., Asselin, B. L., Barr, R. D., Clavell, L. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035153 · Cited by 623
Sleijfer, S. (2001) · Chest · doi:10.1378/chest.120.2.617 · Cited by 611
Risk of Cardiac Death After Adjuvant Radiotherapy for Breast Cancer
Giordano, S. H., Kuo, Y.-F., Freeman, J. L., Buchholz, T. A., Hortobagyi, G. N., & Goodwin, J. S. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji067 · Cited by 552
山口, 博. (2006) · Mebio oncology · Cited by 516
Radiation-associated cardiovascular disease
Adams, M. J., Hardenbergh, P. H., Constine, L. S., & Lipshultz, S. E. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00227-x · Cited by 506
Cardiovascular Status in Long-Term Survivors of Hodgkin's Disease Treated With Chest Radiotherapy
Adams, M. J., Lipsitz, S. R., Colan, S. D., Tarbell, N. J., Treves, S. T., Diller, L., Greenbaum, N., Mauch, P., & Lipshultz, S. E. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.109 · Cited by 500
Cardiovascular Morbidity in Long-Term Survivors of Metastatic Testicular Cancer
Meinardi, M. T., Gietema, J. A., van der Graaf, W. T. A., van Veldhuisen, D. J., Runne, M. A., Sluiter, W. J., de Vries, E. G. E., Willemse, P. B. H., Mulder, N. H., van den Berg, M. P., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1725 · Cited by 489
Duggan, D. B., Petroni, G. R., Johnson, J. L., Glick, J. H., Fisher, R. I., Connors, J. M., Canellos, G. P., & Peterson, B. A. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.086 · Cited by 487
Krischer, J. P., Epstein, S., Cuthbertson, D. D., Goorin, A. M., Epstein, M. L., & Lipshultz, S. E. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.4.1544 · Cited by 476
Smith, S. C., Greenland, P., & Grundy, S. M. (2000) · Circulation · doi:10.1161/01.cir.101.1.111 · Cited by 465
Cardiac disease following treatment of Hodgkin's disease in children and adolescents.
Hancock, S. L., Donaldson, S. S., & Hoppe, R. T. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.7.1208 · Cited by 443
McDonald, S., Rubin, P., Phillips, T. L., & Marks, L. B. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)00429-o · Cited by 401
Asymptomatic cardiac disease following mediastinal irradiation
Heidenreich, P. A., Hancock, S. L., Lee, B. K., Mariscal, C. S., & Schnittger, I. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00759-9 · Cited by 393
Carmel, R. J., & Kaplan, H. S. (1976) · Cancer · doi:10.1002/1097-0142(197606)37:6<2813::aid-cncr2820370637>3.0.co;2-s · Cited by 385
Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours
O’Sullivan, J. M., Huddart, R. A., Norman, A. R., Nicholls, J., Dearnaley, D. P., & Horwich, A. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg020 · Cited by 378
Kremer, L. C. M., van der Pal, H. J. H., Offringa, M., van Dalen, E. C., & Voûte, P. A. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf167 · Cited by 354
Nichols, C. R., Catalano, P. J., Crawford, E. D., Vogelzang, N. J., Einhorn, L. H., & Loehrer, P. J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1287 · Cited by 348
Long-Term Risk of Cardiovascular Disease in 5-Year Survivors of Testicular Cancer
van den Belt-Dusebout, A. W., Nuver, J., de Wit, R., Gietema, J. A., ten Bokkel Huinink, W. W., Rodrigus, P. T. R., Schimmel, E. C., Aleman, B. M. P., & van Leeuwen, F. E. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.7193 · Cited by 345
Subclinical Late Cardiomyopathy After Doxorubicin Therapy for Lymphoma in Adults
Hequet, O., Le, Q. H., Moullet, I., Pauli, E., Salles, G., Espinouse, D., Dumontet, C., Thieblemont, C., Arnaud, P., Antal, D., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.033 · Cited by 340
Jensen, B. V., Skovsgaard, T., & Nielsen, S. L. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf132 · Cited by 336
Chemotherapy and Cardiotoxicity in Older Breast Cancer Patients: A Population-Based Study
Doyle, J. J., Neugut, A. I., Jacobson, J. S., Grann, V. R., & Hershman, D. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.5841 · Cited by 335
Steinherz, L. J., Graham, T., Hurwitz, R., Sondheimer, H. M., Schwartz, R. G., Shaffer, E. M., Sandor, G., Benson, L., & Williams, R. (1992) · Pediatrics · doi:10.1542/peds.89.5.942 · Cited by 327
Lipshultz, S. E., Lipsitz, S. R., Sallan, S. E., Simbre, V. C., Shaikh, S. L., Mone, S. M., Gelber, R. D., & Colan, S. D. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.12.102 · Cited by 308
Paszat, L. F., Mackillop, W. J., Groome, P. A., Boyd, C., Schulze, K., & Holowaty, E. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2625 · Cited by 302
Silber, J. H., Cnaan, A., Clark, B. J., Paridon, S. M., Chin, A. J., Rychik, J., Hogarty, A. N., Cohen, M. I., Barber, G., Rutkowski, M., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.022 · Cited by 299
Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients.
Shapiro, C. L., Hardenbergh, P. H., Gelman, R., Blanks, D., Hauptman, P., Recht, A., Hayes, D. F., Harris, J., & Henderson, I. C. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.11.3493 · Cited by 264
Self-citationLoehrer, P. J., Johnson, D., Elson, P., Einhorn, L. H., & Trump, D. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.2.470 · Cited by 245
Cardiac Morbidity of Adjuvant Radiotherapy for Breast Cancer
Patt, D. A., Goodwin, J. S., Kuo, Y.-F., Freeman, J. L., Zhang, D. D., Buchholz, T. A., Hortobagyi, G. N., & Giordano, S. H. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.13.755 · Cited by 225
Chronic Health Conditions in Adult Survivors of Childhood Cancer
Oeffinger, K. C., Mertens, A. C., & Sklar, C. A. (2007) · Oncology Times · doi:10.1097/01.cot.0000265629.30194.8e · Cited by 187
Pein, F., Sakiroglu, O., Dahan, M., Lebidois, J., Merlet, P., Shamsaldin, A., Villain, E., de Vathaire, F., Sidi, D., & Hartmann, O. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601904 · Cited by 171
Jones, J. M., & Ribeiro, G. G. (1989) · Clinical Radiology · doi:10.1016/s0009-9260(89)80099-6 · Cited by 165
Vallis, K. A., Pintilie, M., Chong, N., Holowaty, E. J., Douglas, P. S., Kirkbride, P., & Wielgosz, A. T. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.4.1036 · Cited by 165
Carotid Stenosis After Radiotherapy for Nasopharyngeal Carcinoma
Cheng, S. W. K., Ting, A. C. W., Lam, L. K., & Wei, W. I. (2000) · Archives of Otolaryngology–Head & Neck Surgery · doi:10.1001/archotol.126.4.517 · Cited by 160
Cardiac safety of liposomal anthracyclines
Ewer, M. S., Martin, F. J., Henderson, I. C., Shapiro, C. L., Benjamin, R. S., & Gabizon, A. A. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.08.006 · Cited by 160
Self-citationReview of Tests for Monitoring Doxorubicin-lnduced Cardiomyopathy
Ganz, W. I., Sridhar, K. S., Ganz, S. S., Gonzalez, R. R., Chakko, S. C., & Serafini, A. N. (2009) · Oncology · doi:10.1159/000227621 · Cited by 151
Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up
Reinders, J. G., Heijmen, B. J. M., Acht, M. J. J. O.-V., van Putten, W. L. J., & Levendag, P. C. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00026-2 · Cited by 148
Mauch, P. M., Kalish, L. A., Marcus, K. C., et al. (2006) · PubMed · Cited by 138
Perez, E. A., Suman, V. J., Davidson, N. E., Kaufman, P. A., Martino, S., Dakhil, S. R., Ingle, J. N., Rodeheffer, R. J., Gersh, B. J., & Jaffe, A. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.516 · Cited by 131
Haynes, J. C., Machtay, M. X., Weber, R. S., Weinstein, G. S., Chalian, A. A., & Rosenthal, D. I. (2002) · The Laryngoscope · doi:10.1097/00005537-200210000-00034 · Cited by 116
Rutqvist, L. E., Liedberg, A., Hammar, N., & Dalberg, K. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00765-7 · Cited by 102
Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin's disease
Constine, L. S., Schwartz, R. G., Savage, D. E., King, V., & Muhs, A. G. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00467-7 · Cited by 100
Kapusta, L., THIJSSEN, J. M., Loonen, J. J., Antonius, T. A. J., Mulder, J., & Daniëls, O. (2000) · Ultrasound in Medicine & Biology · doi:10.1016/s0301-5629(00)00252-0 · Cited by 76
Cumulative incidence and risk factors of mitoxantrone-induced cardiotoxicity in children
van Dalen, E. C., van der Pal, H. J. H., Bakker, P. J. M., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.12.006 · Cited by 65
van der Pal, H. J. H., van Dalen, E. C., Kremer, L. C. M., et al. (2005) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2005.03.008 · Cited by 55
Late cardiac evaluation of children with solid tumors after anthracycline chemotherapy
Pınarlı, F. G., Oğuz, A., Tunaoglu, F. S., Karadeniz, C., Gökçora, N., & Elbeğ, Ş. (2004) · Pediatric Blood & Cancer · doi:10.1002/pbc.20281 · Cited by 54
Tripathy, D., Seidman, A. D., Keefe, D. L., Hudis, C. A., Paton, V. E., & Liebérman, G. (2004) · Clinical Breast Cancer · doi:10.3816/cbc.2004.n.033 · Cited by 33
Risk factors for development of daunorubicin cardiotoxicity.
Hoff, V., & Layard, M. W. (1981) · PubMed · Cited by 27
6. RADIOTHERAPY FOR EARLY AND ADVANCED BREAST CANCER
Harris, S. (2001) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2001.tb11140.x · Cited by 13
Cited by
Benson, A. B., Abrams, T. A., Ben-Josef, E., Bloomston, P. M., Botha, J. F., Clary, B. M., Covey, A., Curley, S. A., D'Angelica, M. I., Davila, R., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0027 · Cited by 2,268
Plana, J. C., Galderisi, M., Barac, A., Ewer, M. S., Ky, B., Scherrer-Crosbie, M., Ganame, J., Sebag, I. A., Agler, D. A., Badano, L. P., et al. (2014) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.07.012 · Cited by 1,795
Self-citationEarly Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Cardinale, D., Colombo, A., Bacchiani, G., Tedeschi, I., Meroni, C. A., Veglia, F., Civelli, M., Lamantia, G., Colombo, N., Curigliano, G., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013777 · Cited by 1,733
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Thavendiranathan, P., Poulin, F., Lim, K.-D., Plana, J. C., Woo, A., & Marwick, T. H. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.073 · Cited by 1,079
Metadata
- Authors
- Carver, J. R., Shapiro, C. L., Ng, A., Jacobs, L., Schwartz, C., Virgo, K. S., Hagerty, K. L., Somerfield, M. R., & Vaughn, D. J.
- Venue
- Journal of Clinical Oncology
- Published
- 2007-09-01
- Volume
- 25
- Issue
- 25
- Pages
- 3991-4008
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2102708069
- Cited by
- 793
- References
- 73
- FWCI
- 27.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.